Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

A simultaneous population pharmacokinetic analysis of rifampicin in Malawian adults and children.

Schipani A, Pertinez H, Mlota R, Molyneux E, Lopez N, Dzinjalamala FK, van Oosterhout JJ, Ward SA, Khoo S, Davies G.

Br J Clin Pharmacol. 2016 Apr;81(4):679-87. doi: 10.1111/bcp.12848. Epub 2016 Jan 30.

2.

Pharmacokinetics of Antituberculosis Drugs in HIV-Positive and HIV-Negative Adults in Malawi.

van Oosterhout JJ, Dzinjalamala FK, Dimba A, Waterhouse D, Davies G, Zijlstra EE, Molyneux ME, Molyneux EM, Ward S.

Antimicrob Agents Chemother. 2015 Oct;59(10):6175-80. doi: 10.1128/AAC.01193-15. Epub 2015 Jul 27.

3.

Persistence of Sulfadoxine-Pyrimethamine Resistance Despite Reduction of Drug Pressure in Malawi.

Artimovich E, Schneider K, Taylor TE, Kublin JG, Dzinjalamala FK, Escalante AA, Plowe CV, Laufer MK, Takala-Harrison S.

J Infect Dis. 2015 Sep 1;212(5):694-701. doi: 10.1093/infdis/jiv078. Epub 2015 Feb 11.

4.

Return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi.

Frosch AE, Laufer MK, Mathanga DP, Takala-Harrison S, Skarbinski J, Claassen CW, Dzinjalamala FK, Plowe CV.

J Infect Dis. 2014 Oct 1;210(7):1110-4. doi: 10.1093/infdis/jiu216. Epub 2014 Apr 9.

5.

Chloroquine-azithromycin combination antimalarial treatment decreases risk of respiratory- and gastrointestinal-tract infections in Malawian children.

Gilliams EA, Jumare J, Claassen CW, Thesing PC, Nyirenda OM, Dzinjalamala FK, Taylor T, Plowe CV, Tracy LA, Laufer MK.

J Infect Dis. 2014 Aug 15;210(4):585-92. doi: 10.1093/infdis/jiu171. Epub 2014 Mar 20.

6.

A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria.

Laufer MK, Thesing PC, Dzinjalamala FK, Nyirenda OM, Masonga R, Laurens MB, Stokes-Riner A, Taylor TE, Plowe CV.

PLoS One. 2012;7(8):e42284. doi: 10.1371/journal.pone.0042284. Epub 2012 Aug 17.

7.

Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment.

Shaukat AM, Gilliams EA, Kenefic LJ, Laurens MB, Dzinjalamala FK, Nyirenda OM, Thesing PC, Jacob CG, Molyneux ME, Taylor TE, Plowe CV, Laufer MK.

Malar J. 2012 Jun 18;11:207. doi: 10.1186/1475-2875-11-207.

8.

Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites.

Laufer MK, Takala-Harrison S, Dzinjalamala FK, Stine OC, Taylor TE, Plowe CV.

J Infect Dis. 2010 Sep 1;202(5):801-8. doi: 10.1086/655659.

9.

Malaria treatment efficacy among people living with HIV: the role of host and parasite factors.

Laufer MK, van Oosterhout JJ, Thesing PC, Dzinjalamala FK, Hsi T, Beraho L, Graham SM, Taylor TE, Plowe CV.

Am J Trop Med Hyg. 2007 Oct;77(4):627-32.

PMID:
17978061
10.

Return of chloroquine antimalarial efficacy in Malawi.

Laufer MK, Thesing PC, Eddington ND, Masonga R, Dzinjalamala FK, Takala SL, Taylor TE, Plowe CV.

N Engl J Med. 2006 Nov 9;355(19):1959-66.

11.

Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children.

Dzinjalamala FK, Macheso A, Kublin JG, Taylor TE, Barnes KI, Molyneux ME, Plowe CV, Smith PJ.

Antimicrob Agents Chemother. 2005 Sep;49(9):3601-6.

12.

Blood folate concentrations and in vivo sulfadoxine-pyrimethamine failure in Malawian children with uncomplicated Plasmodium falciparum malaria.

Dzinjalamala FK, Macheso A, Kublin JG, Taylor TE, Barnes KI, Molyneux ME, Plowe CV, Smith PJ.

Am J Trop Med Hyg. 2005 Mar;72(3):267-72.

PMID:
15772319
13.

Sustained clinical efficacy of sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Malawi after 10 years as first line treatment: five year prospective study.

Plowe CV, Kublin JG, Dzinjalamala FK, Kamwendo DS, Mukadam RA, Chimpeni P, Molyneux ME, Taylor TE.

BMJ. 2004 Mar 6;328(7439):545. Epub 2004 Feb 2. Erratum in: BMJ. 2004 Mar 27;328(7442):762.

14.

Plasmodium falciparum: PCR detection and genotyping of isolates from peripheral, placental, and cord blood of pregnant Malawian women and their infants.

Kamwendo DD, Dzinjalamala FK, Snounou G, Kanjala MC, Mhango CG, Molyneux ME, Rogerson SJ.

Trans R Soc Trop Med Hyg. 2002 Mar-Apr;96(2):145-9.

PMID:
12055802
15.

Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.

Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV.

J Infect Dis. 2002 Feb 1;185(3):380-8. Epub 2002 Jan 17.

PMID:
11807721
16.

Plasmodium falciparum rosette formation is uncommon in isolates from pregnant women.

Rogerson SJ, Beeson JG, Mhango CG, Dzinjalamala FK, Molyneux ME.

Infect Immun. 2000 Jan;68(1):391-3.

Supplemental Content

Loading ...
Support Center